Crucell (www.crucell.com) has granted Invitrogen (www.invitrogen.com) a license to its STAR® technology for the production of mAbs. The STAR platform contains genetic elements, called STAR elements, that enable stable and high-yield gene expression for recombinant antibody and protein production in mammalian cells, Crucell explains.

Next articleUMMZ Periodical Cicada Page